Related Experiment Videos

Management of myelodysplastic syndromes

W J Hirst¹, G J Mufti

¹Department of Haematological Medicine, King's College Hospital School of Medicine and Dentistry, London.

British Journal of Haematology

|June 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.

Bone marrow transplantation·2021

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia.

Leukemia·2018

Preclinical modeling of myelodysplastic syndromes.

Leukemia·2017

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes.

Bone marrow transplantation·2017

The Scope of Viral Vectors for the Transduction of Haemopoietic Cells.

Hematology (Amsterdam, Netherlands)·2016

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2016

See all related articles